Overview
Status
Active
Registry date
2011-08-02
Share capital
5,000.00 PLN
Registered address
ul. Święty Marcin 29/8, 61-806 Poznań, Poland
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 845 days for 2020).
- 2025filed
- 202410/05/2025
- 202311/03/2025
- 202207/02/2024
- 202103/07/2022
- 202007/02/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Przemysław Nowacki – President of the Management Board
Manner of representation
Each of the members of the management board is authorized to submit declarations of will and sign documents on behalf of the company independently, both in the event that a one-person management board is appointed and in the event that a multi-member management board is appointed.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Marta Kaczmarek-Trzybińskaage 50 | 25 | $337.66 | 25% |
Honorata Agnieszka Nabzdyjakage 48 | 34 | $459.21 | 34% |
Przemysław Nowackiage 49 | 33 | $445.71 | 33% |
Others | 8 | $108.05 | 8% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Pura Lineasp. z o.o. | 9,454.35 USD | 70% | ||
Ech-Tcsp. z o.o. | 675.31 USD | 25% |
Bank accounts
Registered as a VAT taxpayer on 2011-07-19.
83 1160 2202 0000 0001 9175 6961
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| GenxoneS.A. | $665,361.35 | genxone.eu | ||
| Polbiotech Laboratoriumsp. z o.o. | $645,943.81 | polbiotech.pl | ||
| Relvosp. z o.o. | $120,693.26 | relvo.pl | ||
| Microblicsp. z o.o. | $122,383.50 | microblic.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| Innervisionsp. z o.o. | $4.54 | innervision.pl | ||
| ImmunotronicsP.S.A. | $0.16 | immunotronics.net | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com | ||
| MIMO BiotechP.S.A. | – | mimobiotech.com |
Change history
| Date | Event | |
|---|---|---|
| 2023-12-29 | Address change (Ul. Mogileńska 4b/14, 61-052, Poznań → Ul. Święty Marcin 29/8, 61-806, Poznań) | |
| 2015-12-01 | Name change (Proenvirotech → Bluecorp) | |
| 2015-04-23 | Address change (Narutowicza 29/2, 64-100, Leszno → Ul. Mogileńska 4b/14, 61-052, Poznań) | |
| 2015-04-23 | PKD change (Removed: 78 codes; Added: 1 code) | |
| 2013-04-29 | Name change (Financial Consulting → Proenvirotech) |
FAQ
The main business activity of Bluecorp focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on August 2, 2011.
The headquarters is located at: ul. Święty Marcin 29, 61-806 Poznań.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $2, representing a decrease of 99.8% compared to 2023.
No, in 2024 the company reported a net loss of $928.
The largest operating cost category falls under external services. This category amounted to $931 in 2024, representing 100% of all operating expenses.
Last updated: 2026-04-21